|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 369.96 USD | -0.26% |
|
-8.97% | -6.96% |
| 01-13 | Alnylam Pharmaceuticals CEO on Development Goals, Profitability | MT |
| 01-12 | Alnylam Pharmaceuticals, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















